Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy

Brachytherapy

Volumn 7, Issue 1, 2008, Pages 17-21

  Lee, Hoon K ^a,b   Adams, Marc T ^a,b   Motta, Joseph ^a  

^a RICHMOND UNIVERSITY MEDICAL CENTER   (United States)

^b Regional Imaging and Therapeutic Radiology Services   (United States)

Author keywords

Biochemical failure; Brachytherapy; Prostate cancer; Radiation therapy; Salvage

Indexed keywords

LEAD 103; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; ARTICLE; BIOCHEMISTRY; BRACHYTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMORBIDITY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HEALTH CARE ORGANIZATION; HORMONAL THERAPY; HUMAN; LIFE EXPECTANCY; MORBIDITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SURGERY; RADIATION DOSE; SAFETY; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; URETHRA SURGERY; UROGENITAL TRACT MALFORMATION;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BRACHYTHERAPY; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PALLADIUM; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOISOTOPES; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 39549122453     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.11.002     Document Type: Article

References (21)

1. Kupelian P., Kuban D., Thames H., et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 61 (2005) 415-419
2. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
3. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
4. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
5. Bianco Jr. F.J., Scardino P.T., Stephenson A.J., et al. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 448-453
6. Stephenson A.J., Scardino P.T., Bianco Jr. F.J., et al. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172 (2004) 2239-2243
7. Stephenson A.J., and Eastham J.A. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol 23 (2005) 8198-8203
8. Pisters L.L., von Eschenbach A.C., Scott S.M., et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 157 (1997) 921-925
9. Izawa J.I., Madsen L.T., Scott S.M., et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: Variables affecting patient outcome. J Clin Oncol 20 (2002) 2664-2671
10. Perrotte P., Litwin M.S., McGuire E.J., et al. Quality of life after salvage cryotherapy: The impact of treatment parameters. J Urol 162 (1999) 398-402
11. Spiess P.E., Lee A.K., Leibovici D., et al. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 107 (2006) 275-280
12. Merrick G.S., Wallner K.E., and Butler W.M. Prostate cryotherapy: More questions than answers. Urology 66 (2005) 9-15
13. Han K.R., and Belldegrun A.S. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 93 (2004) 14-18
14. Pisters L.L., Perrotte P., Scott S.M., et al. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol 17 (1999) 2514-2520
15. Beyer D.C. Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54 (1999) 880-883
16. Zelefsky M.J., Yamada Y., Cohen G., et al. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: Improved dose distributions with an intraoperative computer-optimized conformal planning technique. Int J Radiat Oncol Biol Phys 48 (2000) 601-608
17. Zelefsky M.J., Yamada Y., Marion C., et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 55 (2003) 956-963
18. Grado G.L., Collins J.M., Kriegshauser J.S., et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53 (1999) 2-10
19. Zagars G.K., and Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol 44 (1997) 213-221
20. D'Amico A.V., Moul J., Carroll P.R., et al. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol 172 (2004) S42-S46 discussion S46-S47
21. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499